Orphazyme A/S ADR (ORPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 03-2001 | 12-2000 | 09-2000 | 06-2000 | |
| Gross Profit | 1,990 | 2,050 | 2,610 | 2,170 | 2,590 |
| Operating Expenses | 1,210 | 900 | 2,040 | 1,690 | 1,340 |
| Operating Income | -1,210 | -900 | -2,040 | -1,690 | -1,340 |
| Pre-tax Income | -1,210 | -900 | -2,040 | -1,690 | -1,340 |
| Net Income Continuous | -1,210 | -900 | -2,040 | -1,690 | -1,340 |
| Net Income | $-1,210 | $-900 | $-2,040 | $-1,690 | $-1,340 |
| EBITDA(a) | $-1,170 | $-860 | $-2,000 | $-1,650 | $-1,310 |